Blog

AI tools to improve diagnosis and therapy in neuro-oncology

Pearl Freier and Javier E Villanueva-Meyer

Nov 13, 2024, 09:39

AI tools to improve diagnosis and therapy in neuro-oncology

Pearl Freier, Founder of Cambridge BioPartners, shared a recent article by Javier E Villanueva-Meyer on X:

“AI tools to improve diagnosis and therapy in neuro-oncology are increasing and The Lancet Oncology review provides an assessment of the field with focus on Artificial Intelligence for Response Assessment in Neuro Oncology.

AI models of key genomic markers and predictive AI models of response before and after therapy.”

Title: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements

Authors: Javier E Villanueva-Meyer, Spyridon Bakas, Janine M Lupo, Evan Calabrese, Christos Davatzikos, Wenya Linda Bi, Marwa Ismail, Hamed Akbari, Philipp Lohmann, Thomas C Booth, Benedikt Wiestler, Hugo J W L Aerts, Ghulam Rasool, Joerg C Tonn, Martha Nowosielski, Rajan Jain, Rivka R Colen, Sarthak Pati, Ujjwal Baid, Philipp Vollmuth, David Macdonald, Michael A Vogelbaum, Susan M Chang, Raymond Y Huang and Norbert Galldiks

Pearl Freier-AI tools-neuro-oncology

For more updates, follow OncoDaily.

AI tools cancer Evan Calabrese Janine M Lupo Javier E Villanueva-Meyer Michael A. Vogelbaum Neuro-Oncology Norbert Galldiks OncoDaily Oncology Pearl Freier Raymond Y Huang Spyridon Bakas Susan M. Chang The Lancet Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage